SCHEMBL21708747

SCHEMBL21708747

CCCC(F)OC(=O)CC(CN)c1c(F)cccc1OC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.36
TAS1R1 Q7RTX1 2/20 0.36
PTGFR P43088 3/20 0.35
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
NPSR1 Q6W5P4 2/20 0.33
JAK2 O60674 1/20 0.33
HSP90AA1 P07900 1/20 0.33
RAB9A P51151 1/20 0.33
GAA P10253 1/20 0.33
TSHR P16473 1/20 0.33
KMT2A Q03164 1/20 0.32
PDE4D Q08499 1/20 0.32
POLB P06746 1/20 0.32
HTT P42858 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21708602 0.85 SMN1; SMN2 (0.33) PTGFRTSHRKMT2AL3MBTL1SMN1; SMN2
SCHEMBL21708643 0.84 POLB (0.45) TAS1R3TAS1R1NPSR1GAATSHR
SCHEMBL21708694 0.82 TAS1R3 (0.37) TAS1R3TAS1R1PTGFRGABRA1GABRG2
SCHEMBL21708781 0.81 KMT2A (0.39) TAS1R3TAS1R1PTGFRNPSR1TSHR
SCHEMBL21708580 0.81 KMT2A (0.34) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL21708613 0.80 TAS1R3 (0.33) TAS1R3TAS1R1PTGFR
SCHEMBL21708792 0.80 TAS1R3 (0.33) TAS1R3TAS1R1TSHRKMT2A
SCHEMBL21631909 0.80 GAA (0.50) PTGFRNPSR1GAATSHRKMT2A
SCHEMBL21656364 0.79 MTNR1A (0.40) PTGFRNPSR1JAK2HSP90AA1RAB9A
Hydrochloric Acid SCHEMBL21708784 0.79 GAA (0.37) TAS1R3TAS1R1PTGFRGAACTSA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed